Johnson & Johnson (JNJ) Stock Price, Quote & News

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 732 524 0400

Website: www.jnj.com

Address:

One Johnson & Johnson Plaza, New Brunswick, United States

News4U Jan. 20 at 8:37 PM

$NFLX $INTC $SPY $JNJ $UAL

0 · Reply

cubie Jan. 20 at 8:20 PM

$JNJ @judgeyoung2 interesting 😅

0 · Reply

Svitlana Jan. 20 at 8:19 PM

$IBKR $JNJ $NFLX $SCHW $UAL

0 · Reply

cubie Jan. 20 at 8:08 PM

Earnings After Bell so Place ur Bets: $NFLX $80 or $95-$96 $UAL $100 or $115-$116S $IBKR $65-$67 or $75-$77 Before da bell: $JNJ 204s or 230-$232 $SCHW $92S-$94 or $110

1 · Reply

Arunas1 Jan. 20 at 6:57 PM

$JNJ $MRNA I said I am out this trade. Don’t waste my time with your joke. You have no idea but obviously you are perplexed subconsciously your scared. So you got the wrong guy. Don’t even reply. 👑🧞‍♂️👑

0 · Reply

Deeznutsswapmeet Jan. 20 at 6:54 PM

$JNJ $MRNA How many horrible predictions can you make in one day?

0 · Reply

eWhispers Jan. 20 at 6:31 PM

#earnings before the open on Wednesday, January 21, 2026 https://www.earningswhispers.com/calendar $JNJ $HAL $SCHW $TEL $PLD

0 · Reply

Arunas1 Jan. 20 at 5:52 PM

$CCL $GOOGL $HAL $JNJ $SLB out of respect I am out of these trades now . .

0 · Reply

Sarge986 Jan. 20 at 4:44 PM

. JNJ Hit an All-Time High This Month. What Its Chart Says Now - #JNJ $JNJ TradingView #MarketRecon @moomoo @tradingview .. . https://www.tradingview.com/chart/JNJ/eO59XtQg-JNJ-Hit-an-All-Time-High-This-Month-What-Its-Chart-Says-Now/

0 · Reply

lebranjames Jan. 20 at 4:30 PM

$LEGN $JNJ earnings leaked… CARVYKTI sales way up

0 · Reply

How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q4 Earnings

Jan 19, 2026, 8:00 AM EST - 1 day ago

Is Johnson & Johnson A Dividend Stock, Or Something Else?

Jan 19, 2026, 5:08 AM EST - 1 day ago

Johnson & Johnson: Tempering Expectations After A Massive 2025 (Downgrade)

$TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide$

Jan 14, 2026, 4:30 PM EST - 5 days ago

TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide

Jan 13, 2026, 8:00 AM EST - 7 days ago

Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting

Jan 13, 2026, 2:40 AM EST - 7 days ago

Mar Vista U.S. Quality Q4 2025 Top Contributors And Detractors

DHR GOOG LIN MSFT ORCL

Jan 12, 2026, 6:32 PM EST - 7 days ago

Johnson & Johnson's $1 billion loss from robotics takeover reduced by Delaware top court

Jan 12, 2026, 2:06 PM EST - 8 days ago

Johnson & Johnson (JNJ) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 11, 2026, 7:40 AM EST - 9 days ago

The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips

AMGN CVX HD KO MRK NKE PG

Jan 10, 2026, 10:00 AM EST - 10 days ago

RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Jan 10, 2026, 9:52 AM EST - 10 days ago

January Dogs Of The Dow: One Ideal 'Safer' Dividend Buy

AMGN CRM DIS HD HON KO MRK

Jan 9, 2026, 9:59 AM EST - 11 days ago

Cramer's Mad Dash: Johnson & Johnson

Jan 9, 2026, 5:10 AM EST - 11 days ago

Johnson & Johnson Strikes Deal With White House to Lower Drug Prices

Jan 8, 2026, 9:33 PM EST - 11 days ago

Johnson & Johnson Reaches Deal With Trump Administration to Lower Drug Prices

Jan 8, 2026, 8:43 PM EST - 11 days ago

Johnson & Johnson reaches deal with US government to lower drug prices

Jan 8, 2026, 8:24 PM EST - 11 days ago

Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments

Jan 7, 2026, 8:00 AM EST - 13 days ago

Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration

Jan 6, 2026, 8:03 AM EST - 14 days ago

Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity in a Phase 2 study

$Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma$

Jan 6, 2026, 6:52 AM EST - 14 days ago

Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma

Jan 2, 2026, 5:06 PM EST - 17 days ago

Dogs Of The Dow: 10 High-Yield Stocks With Dividends Up To 6.8% - Including Several Warren Buffett Favorites

AMGN CVX HD KO MRK NKE PG

Jan 2, 2026, 4:17 PM EST - 17 days ago

Dow Jones 2025 Scorecard: Caterpillar, Nvidia Help Index Hit All-Time Highs – Top 5 Winners & Losers

CAT NVDA GS IBM

Jan 2, 2026, 8:00 AM EST - 18 days ago

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026

Dec 31, 2025, 8:47 AM EST - 20 days ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR

Dec 30, 2025, 1:31 PM EST - 21 days ago

The Big 3: JNJ, SNDK, TWLO

TWLO SNDK

Dec 30, 2025, 9:55 AM EST - 21 days ago

Jim Cramer Says ‘The Year of Magical Investing' Is Over—Here's What To Do Now

Dec 30, 2025, 5:05 AM EST - 21 days ago

More Upside For JNJ Stock In 2026?

Dec 29, 2025, 1:56 PM EST - 22 days ago

Dogs of the Dow Had a Strong Year as Dividends Paid Off

HD IBM NKE UNH

Dec 29, 2025, 8:00 AM EST - 22 days ago

Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies

Dec 28, 2025, 6:44 AM EST - 23 days ago

Best Dividend Kings: December 2025

ABBV ABM ABT ADM ADP AWR BDX

Dec 26, 2025, 8:13 AM EST - 25 days ago

Johnson & Johnson halts mid-stage trial of experimental eczema drug

Dec 23, 2025, 11:41 AM EST - 4 weeks ago

J&J ordered to pay record $1.5B in talc cancer lawsuit — while vowing to appeal ‘unconstitutional' ruling

Dec 23, 2025, 12:34 AM EST - 4 weeks ago

J&J vows appeal after US jury hits it with record $1.5 billion talc cancer award

Dec 22, 2025, 11:15 PM EST - 4 weeks ago

Over $1.5 Billion Baltimore Verdict Holds Johnson & Johnson Liable Over Iconic Baby Powder

Dec 20, 2025, 3:55 AM EST - 4 weeks ago

Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder

Dec 19, 2025, 5:54 PM EST - 4 weeks ago

Minnesota Jury Delivers $65.5 Million History-Making Verdict Against Johnson & Johnson

Dec 18, 2025, 8:00 AM EST - 4 weeks ago

Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma

Dec 18, 2025, 2:09 AM EST - 4 weeks ago

Johnson & Johnson: Valuation Premium Justified By Accelerating Growth And Mix Premiumization

Dec 17, 2025, 6:49 PM EST - 4 weeks ago

U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE® (lazertinib)

Dec 15, 2025, 6:22 PM EST - 5 weeks ago

Final Trade: JNJ, NVO, UBER, BMY

BMY NVO UBER

Dec 15, 2025, 4:27 PM EST - 5 weeks ago

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

Dec 15, 2025, 10:39 AM EST - 5 weeks ago

US FDA grants priority voucher to J&J's blood cancer treatment

Dec 14, 2025, 9:00 AM EST - 5 weeks ago

California Jury Awards $40 Million in Landmark Talc Verdict Against Johnson & Johnson

Dec 12, 2025, 9:08 PM EST - 5 weeks ago

Jury orders Johnson & Johnson to pay $40 million to two women in latest talc trial

Dec 12, 2025, 8:25 PM EST - 5 weeks ago

U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*

Dec 11, 2025, 7:05 PM EST - 5 weeks ago

Johnson & Johnson: Reliable Cash Flows, Moderate Expectations

Dec 9, 2025, 9:50 PM EST - 5 weeks ago

GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities

ACN DHI HON KVUE ORCL SSB WFC

Dec 9, 2025, 12:18 PM EST - 6 weeks ago

5 defensive stocks traders are buying before the Fed rate-cut decision

DUK KO NEE PG

$Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma$

Dec 9, 2025, 7:44 AM EST - 6 weeks ago

Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma

Dec 8, 2025, 4:25 PM EST - 6 weeks ago

Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference

$Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma$

Dec 6, 2025, 9:30 AM EST - 6 weeks ago

Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma

News4U Jan. 20 at 8:37 PM

$NFLX $INTC $SPY $JNJ $UAL

0 · Reply

cubie Jan. 20 at 8:20 PM

$JNJ @judgeyoung2 interesting 😅

0 · Reply

Svitlana Jan. 20 at 8:19 PM

$IBKR $JNJ $NFLX $SCHW $UAL

0 · Reply

cubie Jan. 20 at 8:08 PM

Earnings After Bell so Place ur Bets: $NFLX $80 or $95-$96 $UAL $100 or $115-$116S $IBKR $65-$67 or $75-$77 Before da bell: $JNJ 204s or 230-$232 $SCHW $92S-$94 or $110

1 · Reply

Arunas1 Jan. 20 at 6:57 PM

0 · Reply

Deeznutsswapmeet Jan. 20 at 6:54 PM

$JNJ $MRNA How many horrible predictions can you make in one day?

0 · Reply

eWhispers Jan. 20 at 6:31 PM

#earnings before the open on Wednesday, January 21, 2026 https://www.earningswhispers.com/calendar $JNJ $HAL $SCHW $TEL $PLD

0 · Reply

Arunas1 Jan. 20 at 5:52 PM

$CCL $GOOGL $HAL $JNJ $SLB out of respect I am out of these trades now . .

0 · Reply

Sarge986 Jan. 20 at 4:44 PM

0 · Reply

lebranjames Jan. 20 at 4:30 PM

$LEGN $JNJ earnings leaked… CARVYKTI sales way up

0 · Reply

inspector_gadget86 Jan. 20 at 2:50 PM

$SPY packed schedule of corporate earnings ($NFLX , $JNJ , $INTC ) is crucial for direction, with strong guidance needed to support stock valuations

0 · Reply

ValtorQ Jan. 20 at 2:25 PM

$JNJ defensive pharma with steady accumulation and limited volatility unless litigation headlines flare

0 · Reply

TalkMarkets Jan. 20 at 2:18 PM

Johnson & Johnson Near 52-Week High As CAPLYTA Data Boosts Sentiment $JNJ https://talkmarkets.com/content/stocks--equities/johnson--johnson-near-52-week-high-as-caplyta-data-boosts-sentiment?post=551311&userid=166882

0 · Reply

Pissed_of_retards2 Jan. 20 at 1:54 PM

$NVAX $LLY $AZN and $JNJ should really start thinking now fast to acquire $NVAX. But no less bid than $10-10 billions guys. Later it will be $20 billions.

1 · Reply

Arunas1 Jan. 20 at 12:14 PM

$JNJ idk, dumps back $197.00 before tomorrow $MRNA

0 · Reply

Arunas1 Jan. 20 at 12:12 PM

$JNJ $180 to $170 is way better than $220 $DIA $DJ_F $DJIA

0 · Reply

Arunas1 Jan. 20 at 12:03 PM

$JNJ gaps down $15 - $25

0 · Reply

Arunas1 Jan. 20 at 11:25 AM

$JNJ chill out and get this $20 cheaper. So just chill $MRNA

0 · Reply

Arunas1 Jan. 20 at 11:11 AM

$JNJ $205 today -$12

0 · Reply

Badnanny Jan. 20 at 7:40 AM

$JNJ INTS: I lost my mum to breast cancer, this little known biotechnology company is starting to make big waves and needs big support to finish late stage clinical trials.

0 · Reply

Suite510 Jan. 20 at 4:34 AM

$BTC.X $JNJ $KVUE $MSTR lol time will tell 😂🙈

0 · Reply

telaholcomb Jan. 20 at 4:18 AM

$JNJ lil fishy gotta come back in the river which could play into the 1 week downtrend

0 · Reply

Market Cap	526.82B
Revenue (ttm)	88.82B
Net Income (ttm)	14.07B
EPS (ttm)	N/A
PE Ratio	21.15
Forward PE	19.14
Profit Margin	15.84%
Debt to Equity Ratio	0.50

Volume	8,877,802
Avg Vol	8,671,438
Day's Range	N/A - N/A
Shares Out	2.41B
Stochastic %K	91%
Beta	0.34
Analysts	Strong Sell
Price Target	$213.83